Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This paper was originally published under standard Springer Nature copyright. As of the date of this correction, the Analysis is available online as an open-access paper with a CC-BY license. No other part of the paper has been changed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608346PMC
http://dx.doi.org/10.1038/s41592-018-0193-xDOI Listing

Publication Analysis

Top Keywords

publisher correction
4
correction precision
4
precision accuracy
4
accuracy single-molecule
4
single-molecule fret
4
fret measurements-a
4
measurements-a multi-laboratory
4
multi-laboratory benchmark
4
benchmark study
4
study paper
4

Similar Publications

Purpose: To study the efficacy and safety of pro re nata regimen of brolucizumab, without loading dose, in treatment-naive patients with neovascular age-related macular degeneration (nAMD).

Case Series: Retrospective, observational study. We included all consecutive patients diagnosed with treatment- naïve nAMD undergoing Brolucizumab in Humanitas eye clinic, Turin, Italy between April 2022 and May 2023.

View Article and Find Full Text PDF